News
Dexcom's growth in sensors and U.S. expansion is solid, but slowing revenue growth and high valuation limit upside. Click ...
6d
Zacks Investment Research on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?
Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
CNET Tariff Tracker Index Above, you can check out a chart with the average price of the 11 products included in this piece over the course of 2025.
DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Click here to read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results